| Recruiting | Evaluation of Safety and Immunogenicity of Ad26.Mos4.HIV and CH505 TF chTrimer Combination in Healthy Adults Human Immunodeficiency Virus | Phase 1 | 2024-01-30 |
| Active Not Recruiting | Treatment of Hemorrhagic Fever With Ribavirin Hemorrhagic Fever | Phase 2 | 2022-10-31 |
| Completed | Safety, Tolerability, and Immunogenicity of ALFQ in a HIV Vaccine Containing A244 and B.65321 in Healthy Adult Human Immunodeficiency Virus (HIV), AIDS Virus | Phase 1 | 2022-09-08 |
| Completed | Single or Repeat Dose of G03-52-01 in Adult Subjects Healthy, Botulinum Toxin | Phase 2 | 2022-06-15 |
| Completed | HIV Vaccine in HIV-uninfected Adults HIV | Phase 1 | 2022-02-03 |
| Unknown | Safety and Immunogenicity of a Hantaan Virus DNA Vaccine and a Puumala Virus DNA Vaccine, For The Prevention o Hantaan Virus Nephropathy, Puumala Virus Nephropathy | Phase 2 | 2021-08-23 |
| Withdrawn | FY15-14: Tularemia Vaccine Protocol (NDBR Lot 4) Tularemia | Phase 2 | 2021-06-09 |
| Not Yet Recruiting | Safety and Immunogenicity Study of Venezuelan Equine Encephalomyelitis (VEE) Vaccine as Booster Vaccine in Adu Venezuelan Equine Encephalomyelitis | Phase 2 | 2021-06-01 |
| Completed | PHASE 1 SARS-COV-2-Spike-Ferritin-Nanoparticle (SpFN) Vaccine With ALFQ Adjuvant for Prevention of COVID-19 SARS-CoV-2 Infection | Phase 1 | 2021-04-05 |
| Unknown | A Trial For The Study of Falciparum Malaria Protein 013 Administered Via Intramuscular Injection in Healthy Ad Vaccine Reaction | Phase 1 | 2020-03-20 |
| Unknown | A Trial For The Study of Falciparum Malaria Protein 014 Administered Via Intramuscular Injection in Healthy Ad Vaccine Reaction | Phase 1 | 2020-03-20 |
| Withdrawn | A Clinical Trial to Evaluate Plasmodium Falciparum 7G8 and NF54 Challenge Strains (PfSPZ) in a Head-to-head Co Plasmodium Falciparum | N/A | 2020-03-01 |
| Completed | Combination HTNV and PUUV DNA Vaccine Hantaan Virus Disease, Puumala Virus | Phase 1 | 2019-07-10 |
| Recruiting | An Evaluation of Two PTSD Assessments in an Active Duty and Military Veteran Sample Stress Disorders, Post-Traumatic | — | 2019-04-15 |
| Completed | Evaluate the Infectivity Equivalence of Current and New Lots of Plasmodium Falciparum Strain NF54 Malaria,Falciparum | Phase 1 | 2019-03-04 |
| Recruiting | Phase 2 Safety and Immunogenicity Study of Rift Valley Fever Vaccine Rift Valley Fever | Phase 2 | 2018-10-04 |
| Withdrawn | Chloroquine (CQ) and Azithromycin (AZ) Combination for Malaria Prophylaxis Malaria | Phase 2 | 2018-09-17 |
| Completed | Trial to Evaluate the Safety, Immunogenicity, and Efficacy of Malaria Infection in Malaria Naïve Adults Malaria | Phase 1 | 2018-09-15 |
| Completed | Study Assessing Pharmacokinetics and Bioavailability of Three Novel Triazine Compounds Malaria | EARLY_Phase 1 | 2018-08-10 |
| Unknown | Safety and Immunogenicity of Venezuelan Equine Encephalomyelitis Vaccine in Healthy Adults Venezuelan Equine Encephalomyelitis Virus Disease | Phase 2 | 2018-05-30 |
| Unknown | Comparison of Tetravalent Dengue Virus Purified Inactivated Vaccine and Tetravalent Dengue Virus Live Attenuat Dengue Virus | Phase 1 | 2017-11-08 |
| Withdrawn | ID Recombinant Ricin Toxin A-Chain Vaccine RVEc™ - 3-Dose Primary Series With Boost Ricin Poisoning | Phase 1 | 2017-10-01 |
| Completed | Ascending Doses of Autologous FDP vs FFP Freeze Dried Plasma in Healthy Volunteers | Phase 1 | 2017-02-13 |
| Recruiting | Transcranial Electrical Stimulation (TES) at Slow Oscillation (SO) Frequency During NREM Sleep Sleep Deprivation, Mental Competency | N/A | 2016-10-27 |
| Completed | Is an Antiplaque Chewing Gum (30 mg) Able to Reduce Dental Plaque in a Healthy Population? Plaque Regrowth | Phase 2 | 2016-10-01 |
| Completed | A Single-blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Hantaan Puumala Virus DNA V Hantaan Virus | Phase 1 | 2016-08-30 |
| Enrolling By Invitation | Intravenous Ribavirin Protocol to Treat Individuals With Viral Hemorrhagic Fever Viral Hemorrhagic Fever | N/A | 2016-06-16 |
| Withdrawn | IM Recombinant Ricin Toxin Vaccine (RVEc) - 3-Dose Primary Series With Boost Ricin Poisoning | Phase 1 | 2016-04-01 |
| Withdrawn | TDENV PIV and LAV Dengue Prime-boost Strategy Using AS03B Adjuvant Dengue | Phase 1 | 2016-01-01 |
| Unknown | Safety and Immunogenicity Study of the Western Equine Encephalitis (WEE) Vaccine Western Equine Encephalitis | Phase 2 | 2015-12-15 |
| Completed | Safety and Immunogenicity of Artificial Invaplex (Shigella Flexneri 2a InvaplexAR) Shigellosis, Bacillary Dysentery | Phase 1 | 2015-10-01 |
| Completed | Assessment of a Dengue-1-Virus-Live Virus Human Challenge - (DENV-1-LVHC) Virus Strain Dengue | Phase 1 | 2015-10-01 |
| Withdrawn | Cranial-nerve Non-invasive Neuromodulation (CN-NINM) for Balance Deficits After Mild Traumatic Brain Injury (F Mild Traumatic Brain Injury | N/A | 2015-08-01 |
| Completed | Study of Varying Injection Schedules of TDENV-PIV Vaccine With AS03B Adjuvant and Placebo in Healthy US Adults Dengue | Phase 1 / Phase 2 | 2015-08-01 |
| Withdrawn | Cranial-nerve Non-invasive Neuromodulation (CN-NINM) for Balance Deficits After Mild Traumatic Brain Injury (P Mild Traumatic Brain Injury | N/A | 2015-06-01 |
| Completed | TDENV PIV and LAV Dengue Prime-boost Strategy Dengue | Phase 1 | 2014-12-01 |
| Completed | Phase 1 Safety Study of Dimethyl Sulfoxide Cryopreserved Platelets Thrombocytopenia | Phase 1 | 2014-11-05 |
| Completed | Phase 1 Clinical Trial With Controlled Human Malaria Infection (CHMI) to Evaluate the Safety and Efficacy of t Malaria | Phase 1 | 2014-08-01 |
| Completed | Phase 2a Immunogenicity Study of Hantaan/Puumala Virus DNA Vaccine for Prevention of Hemorrhagic Fever Hemorrhagic Fever With Renal Syndrome | Phase 2 | 2014-07-09 |
| Unknown | Study of Immune Responses Induced by a HIV Vaccine HIV Infections | Phase 2 | 2014-07-03 |
| Enrolling By Invitation | Optimizing Volunteer Comfort for Transcranial Electrical Stimulation (TES): An Assessment Performance Enhancing Product Use, Sleep | N/A | 2014-05-24 |
| Completed | Safety Study of a Capsule-Conjugate Vaccine to Prevent Campylobacter-Caused Diarrhea Campylobacter Infection | Phase 1 | 2014-04-21 |
| Completed | Safety and Tolerability of Antiplaque Chewing Gum in a Gingivitis Population Plaque, Gingivitis | Phase 1 / Phase 2 | 2014-02-25 |
| Completed | Immunization Via Mosquito Bite With Radiation-attenuated Sporozoites Malaria | Phase 1 | 2014-01-24 |
| Unknown | Study of Boosting Strategies After Vaccination With ALVAC-HIV and AIDSVAX® B/E HIV Infections | Phase 2 | 2013-09-24 |
| Completed | Challenge Study of an ETEC Vaccine Enteritis; Escherichia Coli, Enterotoxigenic | Phase 2 | 2013-09-19 |
| Terminated | Safety, Efficacy, and PK of Topical Paromomycin/Gentamicin Cream for Treatment of Cutaneous Leishmaniasis Leishmaniasis, Cutaneous | Phase 2 | 2013-09-01 |
| Completed | Evaluation of CL Detect™ Rapid Test to Detect Cutaneous Leishmaniasis Skin Diseases | — | 2013-06-01 |
| Withdrawn | A Phase I Clinical Trial Immunizing Healthy Adults With the NMRC-M3V-Ad-PfCA Vaccine to Generate Biologic Reag Healthy, Malaria | Phase 1 | 2013-06-01 |
| Completed | Phase 3 Study of Walter Reed (WR) 279,396 and Paromomycin Alone for the Treatment of Cutaneous Leishmaniasis i Cutaneous Leishmaniasis | Phase 3 | 2013-05-01 |
| Completed | Booster Dose (50 µg) of Recombinant Ricin Toxin Vaccine (RVEc™) in Previously Vaccinated Healthy Adults Ricin Poisoning | Phase 1 | 2013-04-30 |
| Completed | Evaluation of a Rapid Diagnostic Device, CL Detect, for the Diagnosis of Cutaneous Leishmaniasis in Tunisia Skin Diseases, Parasitic | — | 2013-01-01 |
| Completed | A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Dengue Fever | Phase 1 | 2012-11-01 |
| Completed | mTBI Mechanisms of Action of HBO2 for Persistent Post-Concussive Symptoms Traumatic Brain Injury With Brief Loss of Consciousness, Post-Concussion Syndrome | Phase 2 | 2012-09-11 |
| Completed | A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Dengue Fever | Phase 1 | 2012-09-01 |
| Completed | Safety Study of Chimeric Vaccine to Prevent ETEC Diarrhea Escherichia Coli Infection | Phase 1 | 2012-08-01 |
| Unknown | Study of Late Boost Strategies for HIV-uninfected Participants From Protocol RV 144 HIV Infections | Phase 2 | 2012-04-01 |
| Completed | Study to Evaluate the Safety of a New Oxime, MMB4 DIMETHANESULFONATE (DMS) Safety and Efficacy | Phase 1 | 2012-03-17 |
| Completed | Evaluation of Three Potential Central Nervous System (CNS) Pretreatments for Soman Exposure on Human Performan Biomarkers, Pharmacological | — | 2012-02-01 |
| Unknown | The Use of Near Infrared Spectroscopy in the Diagnosis of Acute Compartment Syndrome in Trauma Patients Anterior Tibial Compartment Syndrome | — | 2012-02-01 |
| Completed | Trial of a Falciparum Malaria Protein (FMP012), E. Coli-expressed PfCelTOS, in Healthy Malaria-Naive Adults Malaria | Phase 1 | 2012-02-01 |
| Completed | Study to Evaluate the Safety, Tolerability, and Immunogenicity of Hantaan and Puumala Virus DNA Vaccines Hemorrhagic Fever With Renal Syndrome | Phase 1 | 2012-01-01 |
| Terminated | WR 279,396 Open Label Treatment Protocol in Tunisia Cutaneous Leishmaniasis | Phase 2 | 2011-12-01 |
| Completed | Evaluation of the Safety and the Ability of a DNA Vaccine to Protect Against Dengue Disease Dengue Disease, Dengue Fever | Phase 1 | 2011-12-01 |
| Completed | Safety Study of a Vaccine (DENV-1 PIV) to Prevent Dengue Disease Dengue Fever | Phase 1 | 2011-12-01 |
| Completed | Safety Study of Recombinant Vaccine to Prevent ETEC Diarrhea Escherichia Coli Infection | Phase 1 | 2011-07-01 |
| Completed | Reference Values for Non-invasive Hydration Status Markers H10-14 Value Orientation | — | 2011-06-01 |
| Completed | Safety and Immunogenicity Study of Recombinant Ricin Toxin A-Chain Vaccine (RVEc™) Ricin | Phase 1 | 2011-03-01 |
| Completed | Hyperbaric Oxygen Therapy (HBO2) for Persistent Post-concussive Symptoms After Mild Traumatic Brain Injury (mT Post-concussive Symptoms, Traumatic Brain Injury | Phase 2 | 2011-02-01 |
| Completed | Study of VMP001 and AS01B (Adjuvant Formulation) in Healthy Malaria-Naïve Adults Malaria, Plasmodium Vivax | Phase 1 / Phase 2 | 2010-07-01 |
| Completed | Safety and Efficacy Study of WRSS1, a Shigella Sonnei Vaccine Candidate Dysentery, Shigella, Diarrhea | Phase 1 / Phase 2 | 2010-05-01 |
| Completed | Pharmacokinetics, Safety, and Efficacy Trial of WR 279,396 (Paromomycin + Gentamicin Topical Cream) and Paromo Leishmaniasis, Cutaneous | Phase 2 | 2010-03-01 |
| Completed | Western Equine Encephalitis Vaccine, Inactivated Virus | Phase 1 | 2010-02-01 |
| Completed | Safety, Efficacy and Pharmacokinetics (PK) Study of WR 279,396 Versus Paromomycin for Treatment of Cutaneous L Leishmaniasis, Cutaneous | Phase 2 | 2010-01-01 |
| Withdrawn | Ribavirin for Hemorrhagic Fever With Renal Syndrome in Germany Hemorrhagic Fever With Renal Syndrome | Phase 2 | 2009-10-01 |
| Completed | Weekly Dosing of Malarone ® for Prevention of Malaria Malaria | Phase 2 | 2009-09-01 |
| Withdrawn | Treatment of Viral Hemorrhagic Fevers With Intravenous Ribavirin in Military Treatment Facilities Crimean-Congo Hemorrhagic Fever, Lassa Fever | Phase 2 | 2009-09-01 |
| Completed | Safety and Immunogenicity Study of Rift Valley Fever Vaccine, Inactivated Rift Valley Fever | Phase 2 | 2009-09-01 |
| Unknown | Continued Safety and Immunogenicity Study of a Live Francisella Tularensis Vaccine Tularemia | Phase 2 | 2009-08-28 |
| Completed | Clinical Trial for Malaria Vaccines to Test for Safety, Immune Response and Protection Against Malaria Malaria | Phase 1 / Phase 2 | 2009-05-01 |
| Completed | Clinical Trial for the Development of a Safe Malaria Challenge Model That Can be Reproduced in Humans Plasmodium Vivax Malaria | Phase 1 | 2009-04-21 |
| Completed | Merozoite Surface Protein 1 Antibody Response in Asymptomatic Human Malaria Infection Malaria | N/A | 2008-09-01 |
| Completed | Safety and Immunogenicity Study of Eastern Equine Encephalitis (EEE) Vaccine Eastern Equine Encephalitis | Phase 2 | 2008-06-03 |
| Completed | Safety and Immunogenicity Study of the Eastern Equine Encephalitis (EEE) Vaccine Eastern Equine Encephalitis | Phase 2 | 2008-06-03 |
| Completed | Evaluate the Safety and Efficacy of Plasmodium Falciparum Malaria Protein 010 (FMP010) Administered With Adjuv Malaria | Phase 1 | 2008-04-01 |
| Completed | A Study to Determine the Effects of an Investigational Malaria Vaccine Given to Adults Living in the United St Malaria | Phase 1 | 2008-04-01 |
| Completed | Phase 1 Safety and Immunogenicity of Meningococcal Vaccine Meningococcal Infection, Group B | Phase 1 | 2008-04-01 |
| Unknown | Safety and Immunogenicity of Venezuelan Equine Encephalomyelitis Vaccine (VEE C-84) as a Booster to VEE TC-83 Venezuelan Equine Encephalomyelitis | Phase 2 | 2008-03-01 |
| Withdrawn | Ribavirin for Hemorrhagic Fever With Renal Syndrome Hemorrhagic Fever With Renal Syndrome | Phase 2 | 2008-02-01 |
| Completed | Phase 3 Study to Evaluate WR 279,396 vs. Paromomycin Alone to Treat Cutaneous Leishmaniasis (in Tunisia) Cutaneous Leishmaniasis | Phase 3 | 2008-01-01 |
| Unknown | Safety and Immunogenicity Study of the Venezuelan Equine Encephalomyelitis Vaccine Venezuelan Equine Encephalomyelitis | Phase 2 | 2007-09-01 |
| Completed | A Study of Two Doses of WRAIR Dengue Vaccine Administered Six Months Apart to Healthy Adults and Children Dengue Fever, Dengue Hemorrhagic Fever, Dengue Shock Syndrome | Phase 2 | 2007-07-01 |
| Completed | Phase II AMA-1 Malaria Vaccine FMP2.1/AS02A Trial in Mali Plasmodium Falciparum Malaria | Phase 2 | 2007-05-01 |
| Completed | Shigella Flexneri 2a Invaplex 50 Vaccine Dose Finding and Assessment of Protection Shigellosis | Phase 1 / Phase 2 | 2007-05-01 |
| Completed | A Phase II Trial of a Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy Adults in Thailand Dengue | Phase 2 | 2007-04-01 |
| Completed | Cosmetic Outcome of Leishmaniasis Scar After WR279396 Application Cutaneous Leishmaniasis, Scar | N/A | 2007-04-01 |
| Terminated | Topical Treatment of Recalcitrant Ulcerative Old World Leishmaniasis With WR 279,396 Cutaneous Leishmaniasis | Phase 2 | 2006-12-20 |
| Completed | Phase I Pediatric FMP2.1/AS02A Trial in Mali Plasmodium Falciparum Malaria | Phase 1 | 2006-11-01 |
| Completed | NMRC-M3V-Ad-PfCA Vaccine - Clinical Trial 1 Plasmodium Falciparum | Phase 1 / Phase 2 | 2006-10-12 |
| Completed | A Study to Determine Whether 2 Investigational Malaria Vaccines Are Safe, Protective Against Malaria in Adults Malaria | Phase 1 / Phase 2 | 2006-09-01 |
| Completed | Safety/Immunogenicity/Genetic Drift of MP-12 Rift Valley Fever Vaccine Rift Valley Fever | Phase 2 | 2006-08-01 |
| Completed | Study of the Safety of Intravenous Artesunate Malaria, Malaria, Cerebral | Phase 1 | 2006-06-12 |
| Completed | Follow up of Thai Adult Volunteers With Breakthrough HIV Infection After Participation in a Preventive HIV Vac HIV-1 | — | 2006-05-01 |
| Completed | Safety and Immunogenicity of Various Formulations of Live Attenuated Tetravalent Dengue Vaccine in Healthy US Dengue | Phase 2 | 2006-04-05 |
| Completed | Phase I/II Trial of a Malaria Vaccine in Adults Living in the United States of America Plasmodium Falciparum Malaria | Phase 1 / Phase 2 | 2006-04-01 |
| Completed | Phase I/II Trial of a Malaria Vaccine in Adults Living in the United States of America Malaria, Plasmodium Falciparum Malaria | Phase 1 / Phase 2 | 2006-04-01 |
| Completed | Safety and Efficacy Study of IV Artesunate to Treat Malaria Malaria | Phase 2 | 2006-03-01 |
| Unknown | Tissue Bank of Biological Specimens From Patients With Gynecologic Disease Endometrial Neoplasms, Uterine Cervical Neoplasms, Ovarian Neoplasms | — | 2006-03-01 |
| Completed | Safety Evaluation of a Q-fever Vaccine, NDBR 105 Q Fever | Phase 2 | 2006-02-01 |
| Unknown | Questionnaire Study for Gynecological Cancer Survivors Endometrial Neoplasms, Ovarian Neoplasms, Uterine Cervical Neoplasms | — | 2006-02-01 |
| Withdrawn | Safety and Immunogenicity of Q Fever Vaccine Q Fever | Phase 2 | 2006-02-01 |
| Completed | Safety and Immunogenicity Study of a Dengue Virus DNA Vaccine Dengue | Phase 1 | 2006-01-01 |
| Completed | Safety and Immunogenicity Study of Group B Meningococcal Vaccine to Prevent Meningitis. Meningitis, Meningococcal, Serogroup B | Phase 1 | 2005-12-05 |
| Unknown | Questionnaire Study to Assess Quality of Life After Treatment of Fibroids Leiomyoma | — | 2005-12-01 |
| Completed | A Study to Evaluate the Efficacy and Tolerance of WR279,396 for Old World Cutaneous Leishmaniasis Old World Cutaneous Leishmaniasis | Phase 2 | 2005-10-01 |
| Withdrawn | Intranasal Recombinant Flagellin Subunit Campylobacter Vaccine (rFla-MBP) Dose-Ranging Study Diarrhea | Phase 1 | 2005-07-01 |
| Completed | Safety of and Immune Response to a Modified Vaccinia Ankara (MVA) HIV Vaccine in HIV Uninfected Adults HIV Infections | Phase 1 | 2005-07-01 |
| Completed | Safety, Immunogenicity of RTS,S/AS02A, and RTS,S/AS01B Malaria Vaccines in Malaria-experienced Adults. Plasmodium Falciparum | Phase 2 | 2005-07-01 |
| Completed | Double-blind, Randomized, Controlled Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vacci Malaria, Falciparum | Phase 2 | 2005-04-08 |
| Completed | A Phase I/II Trial of a Tetravalent Live Attenuated DEN Vaccine in Flavivirus Antibody Naive Children Dengue | Phase 1 / Phase 2 | 2005-02-01 |
| Completed | Comparison of Full-dose Flu Vaccine to Half-dose Flu Vaccine Influenza | Phase 2 | 2004-11-01 |
| Completed | FMP2.1/AS02A: Rabies Vaccine Malaria-Experienced Adults in Bandiagara, Mali Malaria, Plasmodium Falciparum Malaria | Phase 1 | 2004-11-01 |
| Completed | Use of Sodium Stibogluconate as a Treatment for Leishmaniasis Leishmaniasis | Phase 1 / Phase 2 | 2004-10-01 |
| Completed | Safety and Immunogenicity Study of a Live Francisella Tularensis Vaccine Tularemia | Phase 2 | 2004-10-01 |
| Completed | A Phase I Study of Safety and Immunogenicity of the WRAIR HIV-1 Vaccine HIV Infections | Phase 1 | 2004-08-20 |
| Withdrawn | Phase 1 meCS6 + LT(R192G) Vaccine Study Diarrhea | Phase 1 | 2004-08-01 |
| Completed | Safety and Immunogenicity Study of Rift Valley Fever Vaccine Rift Valley Fever | Phase 2 | 2004-06-01 |
| Completed | Invaplex 50 Vaccine Dose-Ranging Diarrhea | Phase 1 | 2004-04-01 |
| Completed | Vietnam Head Injury Study - Phase III Traumatic Brain Injury, Penetrating Head Injury, Closed Head Trauma | — | 2004-04-01 |
| Completed | Local Heat Therapy Versus Sodium Stibogluconate for the Treatment of Cutaneous Leishmaniasis Cutaneous Leishmaniasis | Phase 2 | 2004-02-01 |
| Completed | A Phase I/II Trial of Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naive Infants Dengue | Phase 1 / Phase 2 | 2004-02-01 |
| Completed | Safety and Efficacy Study of RTS,S AS02A/AS01B Vaccine to Prevent Malaria Malaria | Phase 1 / Phase 2 | 2003-12-01 |
| Completed | HIV Vaccine Trial in Thai Adults HIV Infection | Phase 3 | 2003-10-01 |
| Terminated | Study to Evaluate the Efficacy and Safety of Tafenoquine for the Treatment of Plasmodium Vivax in Adults Malaria, Plasmodium Vivax | Phase 2 | 2003-09-15 |
| Completed | A Phase I/II Trial of a Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naïve Children Dengue Fever | Phase 1 / Phase 2 | 2003-08-01 |
| Completed | Safety Study of Candidate Malaria Vaccine FMP1/AS02A in Healthy Adults in Bandiagara, Mali Malaria | Phase 1 | 2003-07-01 |
| Completed | Phase 1 Trial of a Malaria Vaccine in Young Kenyan Children Plasmodium Falciparum Malaria | Phase 1 | 2003-06-01 |
| Completed | Topical Treatment of Cutaneous Leishmaniasis With WR 279,396: A Phase 2 Study in the Old World Cutaneous Leishmaniasis | Phase 2 | 2003-03-01 |
| Completed | Sodium Stibogluconate Treatment of Leishmaniasis Leishmaniasis | Phase 2 | 2002-06-01 |
| Completed | A Safety and Efficacy Study of the Hepatitis E Vaccine in Nepal. Hepatitis | Phase 2 | 2001-07-09 |
| Completed | Safety and Preliminary Efficacy of the Malaria Vaccine Candidates Falciparum Merozoite Protein-1 (FMP1) and Sm Malaria, Falciparum | Phase 1 / Phase 2 | 2001-04-01 |
| Completed | An Evaluation of Weekly Tafenoquine Falciparum Parasitaemia | Phase 2 | 2000-05-01 |
| Completed | Efficacy of an Oral, Killed Enterotoxigenic Escherichia Coli Vaccine in Prevention of Diarrhea in Egyptian Inf Diarrhea | Phase 3 | 1998-10-01 |
| Completed | A Randomized, Double-blind, Placebo-controlled Evaluation of Increasing Doses of Weekly Tafenoquine for Chemos Malaria | Phase 2 | 1998-08-01 |
| Completed | Evaluation of Weekly Tafenoquine Malaria | Phase 2 | 1997-05-01 |
| Available | Tecovirimat (ST-246) Treatment for Orthopox Virus Exposure Smallpox, Monkeypox | — | — |
| No Longer Available | Paromomycin for Individuals With Uncomplicated Cutaneous Leishmaniasis Leishmaniasis, Cutaneous | — | — |
| No Longer Available | Treatment Of CORONAVIRUS DISEASE 2019 (COVID-19) With Anti-Sars-CoV-2 Convalescent Plasma (ASCoV2CP) Severe Acute Respiratory Syndrome Coronavirus 2 | — | — |
| No Longer Available | Expanded Access Remdesivir (RDV; GS-5734™) Coronavirus Disease 2019 | — | — |
| No Longer Available | Arbekacin Treatment of Adult Patients With Infections Caused by Multidrug-resistant Bacteria Infection Due to Resistant Organism | — | — |
| Completed | Study of the Safety of Intravenous Artesunate Malaria, Malaria, Cerebral | Phase 1 | — |
| No Longer Available | Tecovirimat Intravenous Treatment for Orthopox Virus Exposure Orthopox Virus Infection | — | — |